The company announces the establishment of Crown Biome Inc, an oral microbiome company in the US
Leucine Rich Bio, South Asia’s first microbiome company, is all set to foray into US healthcare with the establishment of Crown Biome Inc, US-based entity. Helmed by its CEO Bryan Toton, Crown Biome Inc aims to revolutionising oral healthcare through cutting-edge products and solutions. Besides, Leucine Rich Bio will introduce its product range including the gut microbiome test called ‘BugSpeaks’ and the probiotic line called ‘RychBiome’ in the US, which are currently only available in the Asian market.
The oral microbiome refers to the collective genome of the microbes that are present in a person’s mouth. An increasing number of studies demonstrate a close link between chronic diseases and an imbalance in the microbiome.
Kumar Sankaran, Founder and CEO, Leucine Rich Bio, said, “We are thrilled to unveil Crown Biome Inc, a venture that represents years of dedication and passion. Initially, we are planning to conduct a large clinical study in collaboration with Tufts University. This will allow us to unearth new science-based testing and product solutions. Through this, we plan to expand into the dental market in the US. Crown Biome’s focus on the oral microbiome will revolutionise dentistry and pave the way for a new era of comprehensive healthcare. ”
Sankaran added, “Our unique focus on the oral microbiome and our pioneering approach to profiling previously unexplored areas within the oral cavity set us apart from existing competitors in the market. While other products may primarily address traditional oral care needs, our product goes beyond surface-level solutions. The US market provides opportunities for collaboration and partnerships with established players in the microbiome industry. Collaborating with research institutions, healthcare providers, pharmaceutical companies, and other relevant stakeholders can accelerate the development, validation, and commercialisation of microbiome products. Moreover, the openness to adopting new approaches to healthcare and the willingness to invest in personal well-being can create a favourable environment for microbiome-related products and services.”
Bryan Toton, CEO, Crown Biome Inc, said, “With the support of the entire accomplished team of Leucine Rich Bio joining forces, Crown Biome is poised to lead a transformative movement in the healthcare industry. By bridging the gap between dentistry and systemic health, we are determined to unlock new avenues for patient care and well-being. By delving deep into the oral microbiome ecosystem, we offer a comprehensive understanding of its impact on oral health and overall well-being. This allows us to provide personalised recommendations and interventions that are tailored to individuals’ specific needs.”
- Advertisement -